Omnia SanaPlant Comparison
Horse Chestnut vs Boswellia
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Horse Chestnut and Boswellia: they share 5 indicated uses (arthritis / joint pain, cancer (anticancer research), inflammation (general), …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Horse Chestnut | Boswellia | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 2/10 | 9/10 | Stronger for Boswellia |
| Cancer (anticancer research) | 2/10 | 7/10 | Stronger for Boswellia |
| Inflammation (general) | 2/10 | 5/10 | Stronger for Boswellia |
| Pain (general) | 7/10 | 9/10 | Stronger for Boswellia |
| Skin irritation | 2/10 | 5/10 | Stronger for Boswellia |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
The active mixture responsible for the venotonic and anti-oedematous effects; extracts are standardised to it. Escin is available as oral drages and a transdermal gel, with efficacy shown in chronic venous insufficiency and blunt-trauma injury.
The principal anti-inflammatory compounds; AKBA inhibits 5-lipoxygenase. Absorption improves when taken with a high-fat meal.
Additional constituents of the oleo-gum-resin.
Pharmacological Actions
Anti-oedematous and anti-inflammatory - escin reduces vascular permeability in inflamed tissue and exerts venotonic effects on veins
Anti-oedematous and anti-inflammatory - escin reduces vascular permeability in inflamed tissue and exerts venotonic effects on veins
Escin, the triterpene saponin of Aesculus hippocastanum, induces apoptosis and cell-cycle arrest and chemosensitizes breast, hepatocellular, lung and pancreatic cancer cells (preclinical, including in vivo xenograft models).
Anti-inflammatory (inhibits 5-lipoxygenase / leukotriene synthesis and NF-kB signalling); Reduces inflammatory markers (e.g. hs-CRP) and, in one RCT, improved knee joint-space and reduced osteophytes on radiograph
Boswellic acids, especially acetyl-11-keto-beta-boswellic acid (AKBA) from Boswellia serrata, induce cell-cycle arrest and apoptosis and inhibit proliferation, invasion and metastasis across lung, colorectal and prostate cancers (preclinical, incl. in vivo).
Traditional & Indicated Uses
inferred from anti-inflammatory action
Escin shows antiproliferative and pro-apoptotic activity and enhances chemotherapy/immunotherapy efficacy in breast (MCF-7), hepatocellular, lung and pancreatic cancer models; it modulates NF-kappaB, p53, p38 MAPK/ERK and PD-L1 (preclinical).
Relief of haemorrhoid symptoms (venotonic)
inferred from anti-inflammatory action
Chronic venous insufficiency - reduces leg pain, swelling (oedema), heaviness and itching; supports varicose veins
inferred from anti-inflammatory action
Chronic venous insufficiency - reduces leg pain, swelling (oedema), heaviness and itching; supports varicose veins
Osteoarthritis: reduces joint pain and stiffness and improves function (over at least 4 weeks); Supports inflammatory arthritis including rheumatoid arthritis
Boswellia serrata resin and its triterpenoid AKBA arrest the cell cycle and induce apoptosis in non-small-cell lung cancer, suppress colitis-associated colorectal cancer (NF-kB, gut microbiota) and inhibit prostate cancer (IL-17 pathway) in vitro and in vivo (preclinical).
Supportive in inflammatory bowel disease (ulcerative colitis, Crohn's disease)
inferred from anti-inflammatory action
Analgesic (pain relief); Osteoarthritis: reduces joint pain and stiffness and improves function (over at least 4 weeks)
Safety, Cautions & Contraindications
Use only standardised, processed seed extract. Raw conkers, leaves and bark contain toxic esculin and can cause poisoning - never eat raw horse chestnut.
May increase bleeding risk, so use caution with anticoagulant/antiplatelet medicines; use caution in kidney disease and avoid in pregnancy and breastfeeding.
Generally well tolerated; the most commonly reported side effects are mild gastrointestinal symptoms, and allergic reactions are rare.
Boswellic acids can affect drug-metabolising enzymes, so caution is advised when taking other medicines; safety in pregnancy and breastfeeding is not established, so avoid medicinal doses.
External Ids
Botanical Description
Large deciduous tree, to 25-30 m, with a broad domed crown and stout, upward-arching branches. The leaves are opposite and palmately compound, with five to seven large, obovate, toothed leaflets radiating from a long stalk. In spring the tree bears large, showy, upright pyramidal flower spikes ('candles') of white flowers marked with yellow or pink at the base. The glossy brown seeds ('conkers') develop inside a spiky green husk and fall in autumn.[1]
Small to medium deciduous tree with thin, papery, peeling bark. The leaves are pinnately compound with numerous small, toothed leaflets, clustered toward the branch tips. Small, pale yellow to white flowers are borne in axillary racemes. When the bark is cut, it exudes a fragrant, resinous gum (oleo-gum-resin) that hardens into pale, waxy tears - the medicinal part.[12]
Habitat
Native to the Balkan Peninsula, and widely planted and naturalised as an ornamental and avenue tree across temperate Europe, North America and elsewhere.[1]
Native to dry, rocky, hilly terrain of India and parts of the Middle East and North Africa, where it is tapped for its resin much like frankincense (Boswellia sacra).[12]
Harvesting
The bark is deliberately incised and the exuded oleo-gum-resin is allowed to harden and is collected over several days to weeks, then cleaned and graded before use or extraction.[12]
Traditional Uses
Horse chestnut seed has a long folk history as a remedy for varicose veins, haemorrhoids and 'heavy legs', and was also used topically for rheumatic pain and bruising. Modern use is almost exclusively as a standardised seed extract for chronic venous insufficiency, confirming this traditional venous-support reputation.[1]
Boswellia resin (salai guggul) is a mainstay of Ayurvedic medicine for inflammatory joint and respiratory conditions, and has been burned as incense across many cultures. Modern standardised extracts, rich in boswellic acids, are used for osteoarthritis, inflammatory bowel disease and other inflammatory conditions, directly building on this traditional anti-inflammatory reputation.[12]
Preparations
Resin extract standardised to boswellic acid (often AKBA) content, taken as capsules or tablets, ideally with a fat-containing meal to aid absorption.
Dosage
Clinical studies commonly use extracts standardised to around 100-150 mg escin daily, in divided doses. Educational reference only, not a prescription.
The EU herbal monograph gives semi-solid dosage forms containing the equivalent of 0.4% triterpene glycosides calculated as protoaescigenin (or, depending on the preparation, 0.85-20% herbal preparation), applied as a thin layer to the affected area 1-3 times daily, in adults and elderly. Educational reference only, not a prescription.
Clinical trials in osteoarthritis commonly use extracts providing around 100-250 mg of boswellic acids (or several hundred mg of standardised extract) daily, in divided doses, taken with food. Educational reference only, not a prescription.
References
Drug Class Interactions
Not documented
Lookalikes Review
References & Sources
- Idris, S. and Mishra, A. and Khushtar, M (2020) 'Phytochemical, ethnomedicinal and pharmacological applications of escin from Aesculus hippocastanum L. towards future medicine', Journal of Basic and Clinical Physiology and Pharmacology, 31(5). doi:10.1515/jbcpp-2019-0115 Meta-analysis / review
https://doi.org/10.1515/jbcpp-2019-0115 - Penaranda Figueredo, F.A. and Vicente, J. and Barquero, A.A. and Bueno, C.A (2024) 'Aesculus hippocastanum extract and the main bioactive constituent beta-escin as antivirals agents against coronaviruses, including SARS-CoV-2', Scientific Reports, 14(1), pp. 6418. doi:10.1038/s41598-024-56759-y Preclinical
https://doi.org/10.1038/s41598-024-56759-y - Idris, S. and Mishra, A. and Khushtar, M (2023) 'Phytochemical Estimation and Therapeutic Amelioration of Aesculus hippocastanum L. Seeds Ethanolic Extract in Gastric Ulcer in Rats Possibly by Inhibiting Prostaglandin Synthesis', Chinese Journal of Integrative Medicine, 29(9), pp. 818-824. doi:10.1007/s11655-023-3734-9 Preclinical
https://doi.org/10.1007/s11655-023-3734-9 - Quarta, S. and Santarpino, G. and Carluccio, M.A. and Calabriso, N. and Scoditti, E. and Siculella, L. and Damiano, F. and Maffia, M. and Verri, T. and De Caterina, R. and Massaro, M (2022) 'Analysis of the Anti-Inflammatory and Anti-Osteoarthritic Potential of Flonat Fast, a Combination of Plant Extracts, Bromelain and Escin (Aesculus hippocastanum), Evaluated in In Vitro Models of Inflammation Relevant to Osteoarthritis', Pharmaceuticals, 15(10), pp. 1263. doi:10.3390/ph15101263 Preclinical
https://doi.org/10.3390/ph15101263 - Owczarek, A. and Kolodziejczyk-Czepas, J. and Wozniak-Serwata, J. and Magiera, A. and Kobiela, N. and Wasowicz, K. and Olszewska, M.A (2021) 'Potential Activity Mechanisms of Aesculus hippocastanum Bark: Antioxidant Effects in Chemical and Biological In Vitro Models', Antioxidants, 10(7), pp. 995. doi:10.3390/antiox10070995 Preclinical
https://doi.org/10.3390/antiox10070995 - Cheong, D.H.J., Arfuso, F., Sethi, G., Wang, L., Hui, K.M., Kumar, A.P. and Tran, T (2018) 'Molecular targets and anti-cancer potential of escin', Cancer Letters. doi:10.1016/j.canlet.2018.02.027 Preclinical
https://doi.org/10.1016/j.canlet.2018.02.027 - Pittler, M.H. and Ernst, E (2012) 'Horse chestnut seed extract for chronic venous insufficiency', Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD003230.pub4 Meta-analysis / review
https://doi.org/10.1002/14651858.CD003230.pub4 - Gallelli, L (2019) 'Escin: a review of its anti-edematous, anti-inflammatory, and venotonic properties', Drug Design, Development and Therapy, pp. 3425--3437. doi:10.2147/DDDT.S207720 Preclinical
https://doi.org/10.2147/DDDT.S207720 - Wu, X.J., Zhang, M.L., Cui, X.Y., Gao, F., He, Q., Li, X.J., Zhang, J.W., Fawcett, J.P. and Gu, J.K (2011) 'Comparative pharmacokinetics and bioavailability of escin Ia and isoescin Ia after administration of escin and of pure escin Ia and isoescin Ia in rat', Journal of Ethnopharmacology, 139(1), pp. 201--206. doi:10.1016/j.jep.2011.11.003 Preclinical
https://doi.org/10.1016/j.jep.2011.11.003 - European Medicines Agency (HMPC) (2023) 'European Union herbal monograph on Aesculus hippocastanum L., semen, Revision 1'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/european-union-herbal-monograph-aesculus-hippocastanum-l-semen-final-revision-1_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/european-union-herbal-monograph-aesculus-hippocastanum-l-semen-final-revision-1_en.pdf - Cheong, D.H.J., Arfuso, F., Sethi, G., Wang, L., Hui, K.M., Kumar, A.P. and Tran, T (2018) 'Molecular targets and anti-cancer potential of escin', Cancer Letters, pp. 1--8. doi:10.1016/j.canlet.2018.02.027 Preclinical
https://doi.org/10.1016/j.canlet.2018.02.027 - Mazrouei, R. and Raeisi, E. and Lemoigne, Y. and Heidarian, E (2019) 'Activation of p53 Gene Expression and Synergistic Antiproliferative Effects of 5-Fluorouracil and beta-escin on MCF7 Cells', Journal of Medical Signals and Sensors, 9(3), pp. 196-203. doi:10.4103/jmss.JMSS_44_18 Preclinical
https://doi.org/10.4103/jmss.JMSS_44_18 - Yuan, Y. and Wang, P. and Chen, S. and Cao, Z. and Ojha, S.C. and Sun, C. and Wang, G. and Wang, Z. and Gu, J. and Kang, J. and Xue, X (2025) 'Escin inhibits PD-L1 expression by suppressing the p38 MAPK/ERK signalling pathways and synergistically enhances PD-1 inhibitor efficacy in hepatocellular carcinoma', Phytomedicine, 149, pp. 157532. doi:10.1016/j.phymed.2025.157532 Preclinical
https://doi.org/10.1016/j.phymed.2025.157532 - Hussain, Y. and Singh, J. and Meena, A. and Sinha, R.A. and Luqman, S (2023) 'Escin enhanced the efficacy of sorafenib by autophagy-mediated apoptosis in lung cancer cells', Phytotherapy Research, 37(10), pp. 4819-4837. doi:10.1002/ptr.7948 Preclinical
https://doi.org/10.1002/ptr.7948 - Rimmon, A. and Vexler, A. and Berkovich, L. and Earon, G. and Ron, I. and Lev-Ari, S (2013) 'Escin Chemosensitizes Human Pancreatic Cancer Cells and Inhibits the Nuclear Factor-kappaB Signaling Pathway', Biochemistry Research International, 2013, pp. 251752. doi:10.1155/2013/251752 Preclinical
https://doi.org/10.1155/2013/251752 - Domanski, D., Zegrocka-Stendel, O., Perzanowska, A., Dutkiewicz, M., Kowalewska, M., Grabowska, I., Maciejko, D., Fogtman, A., Dadlez, M. and Koziak, K (2016) 'Molecular Mechanism for Cellular Response to beta-Escin and Its Therapeutic Implications', PLoS One, 11(10). doi:10.1371/journal.pone.0164365 Preclinical
https://doi.org/10.1371/journal.pone.0164365 - Gloviczki, M.L., Kakkos, S.K., Urbanek, T., Chuback, J. and Nicolaides, A (2025) 'The role of venoactive compounds in the treatment of chronic venous disease', Journal of Vascular Surgery: Venous and Lymphatic Disorders, 13(5). doi:10.1016/j.jvsv.2025.102258 Preclinical
https://doi.org/10.1016/j.jvsv.2025.102258 - Santiago, F.R., Grillo, L., Amore, M., Carmelino, C., Trejo, J.M.R. and Ulloa, J.H (2026) 'Venoactive drugs in the management of chronic venous disease: A critical appraisal of the evidence and comparison with international guidelines', Vascular Pharmacology. doi:10.1016/j.vph.2026.107614 Preclinical
https://doi.org/10.1016/j.vph.2026.107614 - Pittler, M.H. and Ernst, E (2006) 'Horse chestnut seed extract for chronic venous insufficiency', Cochrane Database of Systematic Reviews, 2006(1), pp. CD003230. doi:10.1002/14651858.CD003230.pub3 Meta-analysis / review
https://doi.org/10.1002/14651858.CD003230.pub3
- Siddiqui, M.Z (2011) 'Boswellia serrata, a potential antiinflammatory agent: an overview', Indian Journal of Pharmaceutical Sciences, 73(3), pp. 255-261. doi:10.4103/0250-474X.93507 Meta-analysis / review
https://doi.org/10.4103/0250-474X.93507 - Majeed, M., Majeed, S., Narayanan, N.K. and Nagabhushanam, K (2019) 'A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee', Phytotherapy Research, 33(5), pp. 1457--1468. doi:10.1002/ptr.6338 Randomized trial
https://doi.org/10.1002/ptr.6338 - Karlapudi, V., Sunkara, K.B., Konda, P.R., Sarma, K.V. and Rokkam, M.P (2022) 'Efficacy and Safety of Aflapin, a Novel Boswellia serrata Extract, in the Treatment of Osteoarthritis of the Knee: A Short-Term 30-Day Randomized, Double-Blind, Placebo-Controlled Clinical Study', Journal of the American Nutrition Association, 42(2), pp. 159-168. doi:10.1080/07315724.2021.2014370 Randomized trial
https://doi.org/10.1080/07315724.2021.2014370 - Kirste, S., Treier, M., Wehrle, S.J., Becker, G., Abdel-Tawab, M., Gerbeth, K., Hug, M.J., Lubrich, B., Grosu, A.L. and Momm, F (2011) 'Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo-controlled, double-blind pilot trial', Cancer, 117(16), pp. 3788-3795. doi:10.1002/cncr.25945 Randomized trial
https://doi.org/10.1002/cncr.25945 - Abdel-Tawab, M., Werz, O. and Schubert-Zsilavecz, M (2011) 'Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data', Clinical Pharmacokinetics, 50(6), pp. 349-369. doi:10.2165/11586800-000000000-00000 Meta-analysis / review
https://doi.org/10.2165/11586800-000000000-00000 - Gomaa, A.A., Mohamed, H.S., Abd-Ellatief, R.B. and Gomaa, M.A (2021) 'Boswellic acids/Boswellia serrata extract as a potential COVID-19 therapeutic agent in the elderly', Inflammopharmacology, 29(4), pp. 1033-1048. doi:10.1007/s10787-021-00841-8 Meta-analysis / review
https://doi.org/10.1007/s10787-021-00841-8 - Khan, M.A., Ali, R., Parveen, R., Najmi, A.K. and Ahmad, S (2016) 'Pharmacological evidences for cytotoxic and antitumor properties of Boswellic acids from Boswellia serrata', Journal of Ethnopharmacology, 191, pp. 315-323. doi:10.1016/j.jep.2016.06.053 Meta-analysis / review
https://doi.org/10.1016/j.jep.2016.06.053 - Ammon, H.P.T (2010) 'Modulation of the immune system by Boswellia serrata extracts and boswellic acids', Phytomedicine, 17(11), pp. 862-867. doi:10.1016/j.phymed.2010.03.003 Meta-analysis / review
https://doi.org/10.1016/j.phymed.2010.03.003 - Alluri, V.K., Kundimi, S., Sengupta, K., Golakoti, T. and Kilari, E.K (2020) 'An Anti-Inflammatory Composition of Boswellia serrata Resin Extracts Alleviates Pain and Protects Cartilage in Monoiodoacetate-Induced Osteoarthritis in Rats', Evidence-Based Complementary and Alternative Medicine, 2020, pp. 7381625. doi:10.1155/2020/7381625 Preclinical
https://doi.org/10.1155/2020/7381625 - Henrotin, Y., Dierckxsens, Y., Delisse, G., Maes, N. and Albert, A (2022) 'Curcuma and Boswellia serrata extract combination for hand osteoarthritis: an open-label pre-post trial', Pharmaceutical Biology, 60(1), pp. 2295-2299. doi:10.1080/13880209.2022.2147550 Clinical study
https://doi.org/10.1080/13880209.2022.2147550 - Cherepanova, M.O. and Subotyalov, M.A (2023) 'Component Composition and Biological Activity of Oleo-Gum Resin from Boswellia serrata (Burseraceae)', Doklady Biological Sciences, 512(1), pp. 336-342. doi:10.1134/S0012496623700643 Meta-analysis / review
https://doi.org/10.1134/S0012496623700643 - Ammon, H.P.T (2016) 'Boswellic Acids and Their Role in Chronic Inflammatory Diseases', Advances in Experimental Medicine and Biology. doi:10.1007/978-3-319-41334-1_13 Preclinical
https://doi.org/10.1007/978-3-319-41334-1_13 - Yu, G., Xiang, W., Zhang, T., Zeng, L., Yang, K. and Li, J (2020) 'Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis', BMC Complementary Medicine and Therapies. doi:10.1186/s12906-020-02985-6 Meta-analysis / review
https://doi.org/10.1186/s12906-020-02985-6 - Lv, M. and Shao, S. and Zhang, Q. and Zhuang, X. and Qiao, T (2020) 'Acetyl-11-Keto-beta-Boswellic Acid Exerts the Anti-Cancer Effects via Cell Cycle Arrest, Apoptosis Induction and Autophagy Suppression in Non-Small Cell Lung Cancer Cells', OncoTargets and Therapy, 13, pp. 733-744. doi:10.2147/OTT.S236346 Preclinical
https://doi.org/10.2147/OTT.S236346 - Xu, F. and Li, W. and Zheng, X.-J. and Hao, Y. and Yang, Y.-H. and Yang, H. and Zhang, S. and Cao, W.-X. and Li, X.-X. and Zhang, X. and Du, G.-H. and Ji, T.-F. and Wang, J.-H (2025) '3-O-Acetyl-11-Keto-beta-Boswellic Acid Suppresses Colitis-Associated Colorectal Cancer by Inhibiting the NF-kB Signaling Pathway and Remodeling Gut Microbiota', Oncology Research, 33(8), pp. 1969-1989. doi:10.32604/or.2025.062386 Preclinical
https://doi.org/10.32604/or.2025.062386 - Zou, B. and Liu, Q. and Long, Y. and Dai, X. and Tian, X. and Zhou, Q (2025) 'Network Pharmacology Combined with Proteomics Reveals That 3-Acetyl-11-keto-beta-boswellic Acid Inhibits the Progression of Prostate Cancer by Regulating the IL-17 Signaling Pathway', ACS Omega, 10(21), pp. 21813-21822. doi:10.1021/acsomega.5c01683 Preclinical
https://doi.org/10.1021/acsomega.5c01683 - Ragab, E.A. and Abd El-Wahab, M.F. and Doghish, A.S. and Salama, R.M. and Eissa, N. and Darwish, S.F (2023) 'The journey of boswellic acids from synthesis to pharmacological activities', Naunyn-Schmiedeberg's Archives of Pharmacology, 397(3), pp. 1477-1504. doi:10.1007/s00210-023-02725-w Preclinical
https://doi.org/10.1007/s00210-023-02725-w - Liu, X., Machado, G.C., Eyles, J.P., Ravi, V. and Hunter, D.J (2018) 'Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis', British Journal of Sports Medicine, 52(3), pp. 167--175. doi:10.1136/bjsports-2016-097333 Meta-analysis / review
https://doi.org/10.1136/bjsports-2016-097333
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.